Singapore played host to more than 200 delegates at the two-day Health Care System & Public Health organized by the National Academy of Medicine (NAM), USA. Held from 3 to 4 February 2020, the...
First-of-its-kind Phase 1 clinical study demonstrate potential of NR in enhancing effect of exercise for older Singaporean adults with hypertension. Global nutraceutical company, ChromaDex Corp....
Supporting the ageing population through innovative technologies. Taiwanese HealthTech start-up, LongGood Meditech first entered the Singapore market in 2016. Aspiring to support the ageing community...
In a collaborative research, funded by the Singapore Economic Development Board, Changi General Hospital, and Abbott, the first part of the SHIELD study aimed to identify factors that are associated...
Researchers from Duke-NUS Medical School and Monash University band together to bring the discovery of a treatment for Alzheimer’s disease closer with better identification of gene targets. From...
Asia’s pioneering palliative care centre marks 10 years of spearheading premier research and education in the field of end-of-life care. In a country largely influenced by Asian culture, death has...
Changing demands for healthcare among Asian populations and raising healthcare costs will push healthcare organizations to a value-based approach to bring better patient care. Based on a report by...
The Ageing and Health Conference for Policymakers and Researchers in Asia was held from 4th – 6th September 2019 in Singapore. It was organised by Duke-NUS’ Centre for Ageing Research and...
New research from King's College London and The Open University could help explain why memory in old age is much less flexible than in young adulthood. Researchers conducted experiments in mice...
New research at Oregon State University suggests that the blue wavelengths produced by light-emitting diodes damage cells in the brain as well as retinas. Prolonged exposure to blue light, such as...
With Asia on track to having the world’s oldest population in the next few decades, the conference will facilitate dialogue among policymakers and researchers on enabling a healthy ageing society....
Currently on Phase IV of its clinical trials, the Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration (ALTAIR) aims to assess both the efficacy and safety...
